Treatment of fuchs' endothelial corneal dystrophy
AssigneesBoard of Regents, The University of Texas System, University of Massachusetts
InventorsVenkateswara V. MOOTHA, David R. COREY, Jiaxin HU, Jonathan K. WATTS
Life of this patent
Estimating the term…
Abstract
Described are compounds and methods useful in the treatment of Fuchs' Endothelial Corneal Dystrophy (FECD).
Claims21
1-266. (canceled)
A method of treating a subject with Fuchs endothelial corneal dystrophy comprising administering a gene editing construct and at least one guide RNA that targets intron 2 of TCF4 or the 3′-UTR of DMPK.
A composition comprising two gene editing RNAs of 30 to 120 nucleotides in length that flank repeat sequences in the genomic region corresponding to intron 2 of TCF4 or the 3′-UTR of DMPK.
A composition comprising a repeat-RNA-targeting guide sequence comprising at least 2 CAG repeats that binds to CUG repeat RNA corresponding to intron 2 of TCF4 or the 3′-UTR of DMPK.
Dependencies are inferred from the claim text.